Alvotech (ALVO) stock
ALVONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as ALVOW
$4.37−0.04 (-0.79%)
Close on Nov 17, 2026Market cap $1.36BP/E 43.7Yield –
Alvotech total assets
Total assets on the balance sheet at the end of each period.
Alvotech's total assets was $1.59B at Jun 30, 2026. For fiscal 2025 it was $1.49B, up 21.8% from the year before. The highest annual figure on record is $1.49B in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.49B | +21.8% |
| FY2024 | Dec 31, 2024 | $1.22B | +28.6% |
| FY2023 | Dec 31, 2023 | $950.09M | +14.7% |
| FY2022 | Dec 31, 2022 | $828.44M | +38.5% |
| FY2021 | Dec 31, 2021 | $597.98M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.59B | +48.6% |
| Q4 FY2025 | Dec 31, 2025 | $1.49B | +56.5% |
| Q2 FY2025 | Jun 30, 2025 | $1.39B | +52.9% |
| Q4 FY2024 | Dec 31, 2024 | $1.22B | +47.4% |
| Q2 FY2024 | Jun 30, 2024 | $1.07B | +78.7% |
| Q4 FY2023 | Dec 31, 2023 | $950.09M | – |
| Q2 FY2023 | Jun 30, 2023 | $910.66M | – |
| Q4 FY2022 | Dec 31, 2022 | $828.44M | – |
| Q4 FY2021 | Dec 31, 2021 | $597.98M | – |
See a number that looks wrong?